Madrigal Pharmaceuticals Inc (MDGL)
312.00
+1.13
(+0.36%)
USD |
NASDAQ |
Dec 24, 16:00
Madrigal Pharmaceuticals Free Cash Flow: -438.32M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics Inc | 142.60M |
| 89bio Inc | -280.54M |
| ADMA Biologics Inc | 78.82M |
| Matinas BioPharma Holdings Inc | -16.95M |
| Viking Therapeutics Inc | -74.25M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -66.98M |
| Cash from Investing (Quarterly) | -202.39M |
| Cash from Financing (Quarterly) | 7.462M |
| Free Cash Flow Per Share (Quarterly) | -3.116 |
| Free Cash Flow to Equity (Quarterly) | -68.24M |
| Free Cash Flow Yield | -6.78% |